Clinical Trials Logo

Clinical Trial Summary

The primary objective of the study: improvement of sportive performances by quantification and performances monitoring of paralympic athletes. The secondary objectives of the study: - quantification and performances monitoring of mechanical performances during the filed tests, the laboratory analysis and the sportive competitions; - quantification and performances monitoring of physiological performances during the filed tests, the laboratory analysis and the sportive competitions; - quantification and risk monitoring of discipline-relative musculo-squeletic troubles, caused by training or using of sportive equipment; - quantification and mechanical monitoring by the made-to-measure or usual sportive material.


Clinical Trial Description

The sportive performance results from a range of determinations such as: physiological, biomechanical, morphological, psychological, social and environmental factors. The interactions between athletes, equipment, training and environment influences the development of athletes' performance. In the context of the coming Paris 2024 Paralympic Games, the performance construction for the exploration, the quantification and the management of all factors is an commun objective between sportive team, medical team and researchers. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04748497
Study type Interventional
Source Assistance Publique - Hôpitaux de Paris
Contact Jean François Toussaint, MD, PhD
Phone +33 (0)1 42 34 82 10
Email jean-francois.toussaint@aphp.fr
Status Recruiting
Phase N/A
Start date January 8, 2021
Completion date June 2024

See also
  Status Clinical Trial Phase
Completed NCT05916352 - Effects of Caffeine on Upper Extremity Performance N/A